Ongoing Studies

ACUITY (ACT-01_P2_01) A randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of ACT-01 in patients with acute optic neuritis

DIAMOND 1 (DX219) A phase 2/3 double-masked, randomized, 2 stage, multicenter study of the efficacy and safety of OCS-01 eye drops in subjects with diabetic macular edema

DIAMOND 2 (DX221) A phase 3 double-masked, randomized, multicenter study of the efficacy and safety of OCS 01 eye drops in subjects with diabetic macular edema

DAPAN DIA A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of the Oral NLRP3 Inhibitor Dapansutrile in Subjects with Type 2 Diabetes Mellitus

RETISOM A Phase II-III multicentric, randomized, double-blind, placebo-controlled trial